Effects of Intragastric Administration of Tryptophan on the Blood Glucose Response to a Nutrient Drink and Energy Intake, in Lean and Obese Men

Nutrients. 2018 Apr 8;10(4):463. doi: 10.3390/nu10040463.

Abstract

Tryptophan stimulates plasma cholecystokinin and pyloric pressures, both of which slow gastric emptying. Gastric emptying regulates postprandial blood glucose. Tryptophan has been reported to decrease energy intake. We investigated the effects of intragastric tryptophan on the glycaemic response to, and gastric emptying of, a mixed-nutrient drink, and subsequent energy intake. Lean and obese participants (n = 16 each) received intragastric infusions of 1.5 g ("Trp-1.5g") or 3.0 g ("Trp-3.0g") tryptophan, or control, and 15 min later consumed a mixed-nutrient drink (56 g carbohydrates). Gastric emptying (13C-acetate breath-test), blood glucose, plasma C-peptide, glucagon, cholecystokinin and tryptophan concentrations were measured (t = 0-60 min). Energy intake was assessed between t = 60-90 min. In lean individuals, Trp-3.0g, but not Trp-1.5g, slowed gastric emptying, reduced C-peptideAUC and increased glucagonAUC (all P < 0.05), but did not significantly decrease the blood glucose response to the drink, stimulate cholecystokinin or reduce mean energy intake, compared with control. In obese individuals, Trp-3.0g, but not Trp-1.5g, tended to slow gastric emptying (P = 0.091), did not affect C-peptideAUC, increased glucagonAUC (P < 0.001) and lowered blood glucose at t = 30 min (P < 0.05), and did not affect cholecystokinin or mean energy intake. In obese individuals, intragastrically administered tryptophan may reduce postprandial blood glucose by slowing gastric emptying; the lack of effect on mean energy intake requires further investigation.

Keywords: cholecystokinin; food intake; glucagon; glycemic control; humans; insulin.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Adult
  • Appetite Depressants / administration & dosage*
  • Appetite Depressants / adverse effects
  • Beverages* / adverse effects
  • Biomarkers / blood
  • Blood Glucose / drug effects*
  • Blood Glucose / metabolism
  • C-Peptide / blood
  • Cholecystokinin / blood
  • Double-Blind Method
  • Energy Intake / drug effects*
  • Food, Formulated* / adverse effects
  • Gastric Emptying / drug effects
  • Glucagon / blood
  • Humans
  • Male
  • Obesity / blood
  • Obesity / diagnosis
  • Obesity / drug therapy*
  • Obesity / physiopathology
  • Postprandial Period
  • South Australia
  • Time Factors
  • Treatment Outcome
  • Tryptophan / administration & dosage*
  • Tryptophan / adverse effects

Substances

  • Appetite Depressants
  • Biomarkers
  • Blood Glucose
  • C-Peptide
  • Tryptophan
  • Glucagon
  • Cholecystokinin